The online reseller trading as Adamant Research Supply closes after 13 years
A proper account of an operation that existed, and of what closing it cost.
The archive
Page 115 of 170 of this archive, newest first.
The dose that got you here and the dose that keeps you here
The commonest real-world strategy in this drug class is the least studied one.
Repackaging, subdivision, and the batch number that changed hands
A document is only as good as the chain that connects it to the material, and most chains here are two or three links longer than the paperwork admits.
What the trials counted as intolerance
We set out the questions that distinguish a symptom to manage from a dose to change.
SELECT extension data: what happens after the trial stops
A design note rather than a result: what the comparator was, and what that permits you to conclude.
Holograms, QR codes and other things that are not verification
Reported from the analysis, not from a warning notice.
The relabeller trading as Vantris Bio enters a consent decree and stops sterile preparation
The observation that closes a facility is rarely the dramatic one.
A supplier suspends shipping to Italy after 10 consecutive customs detentions
The route did not close because of a rule about peptides.
What SURPASS-4 tells us about maintenance, and what it does not
A survey of the maintenance evidence, which is shorter than the survey of the withdrawal evidence.
Independent analysis puts a QST dulaglutide lot at 95.3%, against 91.7% on the certificate
The result is unremarkable. What the report omits is not.
Tianjin export categories for peptide intermediates were quietly renamed
Follow the resin, not the catalogue.
From the floor in Suzhou: 15 posters, one theme
Reported from the sessions, and from the two hours afterwards.
Why summer is a documented quality problem in this trade
The route did not close because of a rule about peptides.
Why your endoscopist wants to know about your injection
Holding a dose before a procedure has a kinetic problem: a weekly drug with a seven-day half-life cannot be cleared by skipping one injection.
The degradation product that elutes underneath the parent peak
An isoaspartate rearrangement changes the molecule and not the mass. A method that confirms identity by molecular weight alone will report it as the parent compound.
What a 37% rise in coupling-reagent prices does to a 2 mg vial
Follow the resin, not the catalogue.
The 6-day notice: how a compounding wind-down works in New Zealand
The document is four pages. Three of them are about dates.
The relabeller trading as Vantris Bio closes after 12 years
A proper account of an operation that existed, and of what closing it cost.
A needle is a single-use instrument
For licensed products the in-use period is established by stability data. For a peptide reconstituted at home there is no such data, and the honest answer is that nobody…
GIP was a failed target for thirty years. Then it was not.
The glucagon arm raises energy expenditure and also raises hepatic glucose output. Balancing those is the whole engineering problem.
SURMOUNT-4 misses on a secondary endpoint the coverage has not mentioned
A design note rather than a result: what the comparator was, and what that permits you to conclude.
A shortage listing ends. 7 pharmacies now have a business model and no legal basis for it.
The document is four pages. Three of them are about dates.
The quiet end of Halvard & Pike Apothecary of Portland, Maine
A proper account of an operation that existed, and of what closing it cost.
The United Arab Emirates caps tirzepatide prescribing to 22 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.
What a laboratory knows about the material it receives
What a laboratory can and cannot know about the provenance, storage history and representativeness of what lands on its bench.
What a mass spectrometer does to a peptide before it measures anything
A brief and unromantic tour of the interface between a liquid sample and a vacuum.
A supplier suspends shipping to Switzerland after 4 consecutive customs detentions
The route did not close because of a rule about peptides.
What a 9% rise in coupling-reagent prices does to a 20 mg vial
Follow the resin, not the catalogue.
Holograms, QR codes and other things that are not verification
Reported from the analysis, not from a warning notice.
Independent analysis puts a TFC dulaglutide lot at 95.8%, against 95.1% on the certificate
The report states the gradient, the wavelength and the integration threshold, which is more than most.